These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9119185)
1. [Cost-effectiveness analysis of the treatment of chronic hepatitis C]. Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185 [TBL] [Abstract][Full Text] [Related]
2. [Compared efficiency of three strategies of management of chronic hepatitis C. Effect on the risk of cirrhosis 8 years after diagnosis]. Michel P; Merle V; Gourier C; Hochain P; Colin R; Czernichow P Gastroenterol Clin Biol; 1996 Feb; 20(1):47-54. PubMed ID: 8734312 [TBL] [Abstract][Full Text] [Related]
3. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Shiell A; Briggs A; Farrell GC Med J Aust; 1994 Mar; 160(5):268-72. PubMed ID: 8107627 [TBL] [Abstract][Full Text] [Related]
4. [Cost effectiveness of the treatment of chronic hepatitis C with interferon-alpha]. Buti M; Casado MA; Fosbrook L; Esteban R Gastroenterol Hepatol; 1998 Apr; 21(4):161-8. PubMed ID: 9633175 [TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of interferon in chronic active hepatitis C. Turnbull C; Sugano D Med J Aust; 1994 Jul; 161(2):169; author reply 170. PubMed ID: 8028544 [No Abstract] [Full Text] [Related]
6. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Dusheiko GM; Roberts JA Hepatology; 1995 Dec; 22(6):1863-73. PubMed ID: 7489999 [TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of interferon in chronic active hepatitis C. Sallie R Med J Aust; 1994 Jul; 161(2):169-70. PubMed ID: 8080533 [No Abstract] [Full Text] [Related]
8. Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries. Aggarwal R; Ghoshal UC; Naik SR Natl Med J India; 2002; 15(6):320-7. PubMed ID: 12540064 [TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications. Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839 [TBL] [Abstract][Full Text] [Related]
11. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C. Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523 [TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States. Brooks EA; Lacey LF; Payne SL; Miller DW Am J Manag Care; 2001 Jul; 7(7):677-82. PubMed ID: 11464426 [TBL] [Abstract][Full Text] [Related]
13. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189 [TBL] [Abstract][Full Text] [Related]
14. [Medico-economic assessment of the therapeutic management of patients with hepatitis C]. Loubière S; Rotily M; Moatti JP Gastroenterol Clin Biol; 2000 Nov; 24(11):1047-51. PubMed ID: 11139674 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial. Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673 [TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C. Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U J Viral Hepat; 2010 Jan; 17(1):34-50. PubMed ID: 19656290 [TBL] [Abstract][Full Text] [Related]
18. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911 [TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance. Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996 [TBL] [Abstract][Full Text] [Related]
20. Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients? Saab S; Ly D; Han SB; Lin RK; Rojter SE; Ghobrial RM; Busuttil RW Liver Transpl; 2002 May; 8(5):449-57. PubMed ID: 12004345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]